Jeena Sikho Lifecare

Jeena Sikho Lifecare

816.20
-4.90
(-0.60%)
Market Cap
10,206.30 Cr
EPS
24.84
PE Ratio
304.01
Dividend Yield
0.13 %
Industry
Healthcare
52 Week High
2,498.60
52 Week Low
400.25
PB Ratio
80.81
Debt to Equity
0.05
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Jeena Sikho Lifecare Limited has incorporated a wholly owned overseas subsidiary named Jeena Sikho International LLC under the Shams Authority in UAE. The subsidiary was incorporated on September 11, 2025, and received a business license valid until September 10, 2027. The company invested AED 100,000 through 100 shares of AED 1,000 each via cash consideration. The subsidiary will operate in the health and care industry, carrying on healthcare and related consultancy activities in UAE, aligned with the parent company's main business. Manish Grover serves as Director and Abraham Manu as General Manager of the new entity. The subsidiary is registered at Shams Business Center, Sharjah Media City Free Zone, UAE.
positive
Jeena Sikho Lifecare Limited has entered into partnerships with Salesforce and Quadrafort Technologies to implement digital changes in Ayurvedic healthcare operations.
positive
Jeena Sikho Lifecare Limited has commenced operations of its new hospital in Jammu on September 11, 2025. The 40-bed facility spans 13,000 sq. ft. and includes 22 rooms and 2 OPDs. The hospital is located at W/No. 68 Greater Kailash Near Indian Oil Petrol Pump Tehsil Bahu, District Jammu. This follows the company's earlier proposal for establishing the hospital that was announced in April 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,656.00
#1 3,95,554.40
34.64
#1 54,729.00
9.71
#1 10,980
-19.84
59.47
6,200.00
1,62,254.40
71.36
9,712.00
18.67
2,191
26.74
48.13
1,575.80
1,27,472.40
23.60
28,409.50
7.12
5,291
9.88
56.43
3,629.20
1,20,737.00
60.86
11,539.40
6.99
1,911
19.91
48.09
1,321.70
1,10,388.70
19.43
33,741.20
16.73
5,725
1.26
62.90
2,660.60
1,08,890.20
58.10
12,744.20
#1 20.90
2,007
-18.14
62.57
1,037.30
1,05,438.20
22.38
23,511.00
18.55
4,615
2.60
66.99
2,055.60
93,467.30
25.39
22,909.50
13.74
3,306
#1 51.64
65.03
30,365.00
65,639.10
44.33
6,684.70
9.64
1,414
11.55
38.96
1,119.20
65,566.70
#1 19.32
32,345.60
9.43
3,484
-10.24
65.06
Forecast
Actual
Growth Rate
Revenue Growth
40.07 %
Net Income Growth
199.11 %
Cash Flow Change
-11.19 %
ROE
-13.14 %
ROCE
-17.44 %
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2022
2023
TTM
Revenue
148
207
0
Expenses
129
159
0
EBITDA
20
48
0
Operating Profit %
12 %
22 %
0 %
Depreciation
3
3
0
Interest
1
1
0
Profit Before Tax
15
44
0
Tax
4
11
0
Net Profit
11
34
0
EPS in ₹
11.11
24.84
0.00

Balance Sheet

Balance Sheet
2022
2023
Total Assets
62
151
Fixed Assets
29
60
Current Assets
22
78
Capital Work in Progress
5
1
Investments
0
5
Other Assets
28
86
Total Liabilities
62
151
Current Liabilities
24
25
Non Current Liabilities
1
1
Total Equity
37
126
Reserve & Surplus
26
112
Share Capital
10
14

Cash Flow

Cash Flow
2022
2023
Net Cash Flow
-7
29
Investing Activities
-19
-33
Operating Activities
16
15
Financing Activities
-5
48

Share Holding

% Holding
Sept 2021
Feb 2022
Apr 2022
Sept 2022
Mar 2023
Sept 2023
Nov 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Aug 2025
Promoter
90.00 %
90.00 %
65.89 %
65.89 %
66.20 %
67.91 %
67.91 %
67.91 %
65.84 %
63.53 %
63.53 %
63.53 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.99 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.18 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.00 %
10.00 %
20.05 %
16.21 %
15.28 %
14.41 %
14.94 %
17.34 %
16.72 %
16.67 %
17.05 %
17.20 %
Others
0.00 %
0.00 %
14.06 %
17.90 %
18.52 %
17.68 %
17.15 %
14.75 %
17.44 %
19.80 %
19.41 %
13.10 %
No of Share Holders
7
6
1,951
834
663
814
1,107
2,721
3,423
5,967
6,603
7,434

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.47
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.67

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 702.30 817.80
22 Sept 2025 DIVIDEND Dividend
₹ 1.10 /share
22 Sept 2025 2,353.90 817.80
25 Aug 2023 DIVIDEND Dividend
₹ 2.00 /share
25 Aug 2023 333.00 1,065.05
02 Nov 2023 BONUS Bonus
4:5
02 Nov 2023 1,195.50 1,403.25
27 Feb 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
27 Feb 2024 641.00 857.80
20 Aug 2024 DIVIDEND Dividend
₹ 4.18 /share
20 Aug 2024 1,121.40 1,416.40
28 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2024 1,147.00 1,351.20
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 1,723.10 1,706.30
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 2,284.55 2,353.90
21 Apr 2025 SPLIT Split
2:10
12 Jun 2025 2,251.25 2,251.25
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 547.35 560.70

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition8 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Intimation Under Regulation 30 Of SEBI (LODR) - Collaboration With Salesforce For Digital Transformation In Ayurvedic Healthcare8 days ago
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Commencement Of Operations Of New Hospital At Jammu8 days ago
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Approval Of Clinical Trial Of Anti-Diabetes Efficacy Of SDM02 TABLETS Shuddhi XS Syrup Petshuddhi Churna And Shuddhi Dr. B P Care Tablets.Sep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Publication Of Case Studies And Reports.Sep 05, 2025
Proposal For Establishment Of New Branch Of Jeena Sikho Lifecare Limited Hospital In Bhagalpur BiharSep 04, 2025
Empanelment Of Jeena Sikho Lifecare Limited Ayurveda Panchkarma Hospital With GIPSA For Providing Cashless Ayurveda Panchkarma Treatment.Sep 04, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Weblink For Notice Of 8Th Annual General Meeting And Annual Report For The Financial Year 2024-25Sep 03, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2025
Notice Of The 8Th Annual General Meeting And Integrated Annual Report For Financial Year 2024-25Sep 03, 2025
Intimation Of Record Date For Final Dividend Under Regulation 42 Of SEBI (LODR) Regulations 2015.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Publication Of Case StudiesAug 28, 2025
The Board At Its Meeting Held On 27Th August 2025 Decided To Hold The 8Th Annual General Meeting Of The Company On Monday 29Th September 2025 At 12:00 Noon.Aug 27, 2025
Book Closure Of The Register Of Members And Share Transfer Books Of The Company From Tuesday September 23 2025 To Monday September 29 2025 (Both Days Inclusive) For The 8Th Annual General Meeting.Aug 27, 2025
Approval Of Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2025Aug 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 27, 2025
Fixation Of Dividend Record DateAug 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th August 2025Aug 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 23, 2025
Board Meeting Intimation for 1. To Consider And Approve The Proposal For Employee Stock Option Scheme 2025 In Terms Of SEBI (Share Based Employee Benefits And Sweat Equity) Regulations 2021. 2. To Consider Any Other Matter With The Permission Of The ChaiAug 23, 2025
Empanelment Of Jeena Sikho Lifecare Limited-Vaishali (Ghaziabad) Gurugram Delhi & Meerut Branches Under CBSE.Aug 22, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Intimation Of NABH Certification For Jeena Sikho Lifecare Limited (Hospital)- Agra And Panchkula BranchAug 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 18, 2025
Clarification On Volume Movement In Jeena Sikho Lifecare LimitedAug 18, 2025
Clarification sought from Jeena Sikho Lifecare LtdAug 18, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 16, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 15, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 14, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 14, 2025
The Un-Audited Financial Results Along With Limited Review Report For Quarter Ended 30Th June 2025Aug 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th August 2025Aug 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Publication Of Research Articles.Aug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 12, 2025
Board Meeting Intimation for Prior Intimation Of Board Meeting For Decalration Of Unaudited Quarterly Financial Results For June Quarter 2025.Aug 11, 2025
Listing of Equity Shares of Jeena Sikho Lifecare LtdAug 11, 2025

Technical Indicators

RSI(14)
Neutral
68.20
ATR(14)
Less Volatile
34.78
STOCH(9,6)
Neutral
77.56
STOCH RSI(14)
Neutral
45.07
MACD(12,26)
Bearish
-0.21
ADX(14)
Very Strong Trend
50.27
UO(9)
Bearish
52.93
ROC(12)
Uptrend And Accelerating
7.63
WillR(14)
Neutral
-22.07